Health
Novel neutralizing antibodies targeting SARS-CoV-2 N-terminal domain discovered – News-Medical.Net
A new study by US-based researchers shows the presence of protective antibodies that target the N-terminal domain (NTD) of the spike instead of the spike receptor-binding…
The main thrust of scientific research on therapeutics to counter the ongoing coronavirus disease 2019 (COVID-19) pandemic has been aimed at identifying drugs and antibodies that can act against the entry of the causative virus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), into the host cell.
A new study by US-based researchers shows the presence of protective antibodies that target the N-terminal domain (NTD) of the spike instead of the spike receptor-binding domain (RBD).
The…
-
Noosa News21 hours agoHow Lily Steele-Park took her rapist to court and won
-
Noosa News22 hours agoE-biker charged with riding dangerously, assaulting cop
-
Business24 hours ago5 things to watch on the ASX 200 on Tuesday 8 July 2025
-
General20 hours agoBrick portico a relic of ‘prestigious’ Horton College in northern midlands